P L Yap|H A Leaver - JoVE Visualize

Showing results (81-90 of 167) with videos related to

Pageof 17

Sort By:

Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 4, 1998

Apoptosis in human primary brain tumours: actions of arachidonic acidJ R Williams, H A Leaver, J W Ironside, et al.

Vox Sanguinis|January 1, 1986

Serum ALT levels in patients with primary hypogammaglobulinaemia receiving replacement therapy with intravenous immunoglobulin or fresh frozen plasmaC L Leen, P L Yap, G Neill, et al.

The Journal of General Virology|October 1, 1995

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study GroupJ Mellor, E C Holmes, L M Jarvis, et al.

Clinical and Experimental Immunology|February 1, 1987

Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.

Transfusion Medicine (Oxford, England)|December 1, 1994

Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virusY Ayob, J I Davidson, A Baxter, et al.

Vox Sanguinis|January 1, 1994

Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary studyF McOmish, P L Yap, H Hart, et al.

Scottish Medical Journal|October 1, 1992

Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected childrenN Croft, P L Yap, J Y Mok, et al.

Clinical and Experimental Immunology|April 1, 1983

Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factorR A Thompson, P L Yap, R B Brettle, et al.

Journal of Clinical Microbiology|February 1, 1993

Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionF McOmish, P L Yap, A Jordan, et al.

Blut|August 1, 1990

Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapyR A Hague, O B Eden, P L Yap, et al.

Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:

Pageof 17

Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 4, 1998

Apoptosis in human primary brain tumours: actions of arachidonic acidJ R Williams, H A Leaver, J W Ironside, et al.

Vox Sanguinis|January 1, 1986

Serum ALT levels in patients with primary hypogammaglobulinaemia receiving replacement therapy with intravenous immunoglobulin or fresh frozen plasmaC L Leen, P L Yap, G Neill, et al.

The Journal of General Virology|October 1, 1995

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study GroupJ Mellor, E C Holmes, L M Jarvis, et al.

Clinical and Experimental Immunology|February 1, 1987

Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.

Transfusion Medicine (Oxford, England)|December 1, 1994

Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virusY Ayob, J I Davidson, A Baxter, et al.

Vox Sanguinis|January 1, 1994

Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary studyF McOmish, P L Yap, H Hart, et al.

Scottish Medical Journal|October 1, 1992

Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected childrenN Croft, P L Yap, J Y Mok, et al.

Clinical and Experimental Immunology|April 1, 1983

Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factorR A Thompson, P L Yap, R B Brettle, et al.

Journal of Clinical Microbiology|February 1, 1993

Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionF McOmish, P L Yap, A Jordan, et al.

Blut|August 1, 1990

Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapyR A Hague, O B Eden, P L Yap, et al.

Pageof 17